Senior Director, HEOR
Vertex Pharmaceuticals
Boston, Massachusetts
Ann Menzie is currently a Senior Director at Vertex Pharmaceuticals leading the global Health Economics and Outcomes Research (HEOR) team for the Pain program. During her 3 year tenure at Vertex, Ann first supported the cystic fibrosis program as the global HEOR brand lead for a novel triple combination therapy before moving into the HEOR Pain role. Prior to joining Vertex, Ann spent 2 years in HEOR and market access consulting and 7 years at Johnson & Johnson leading global and US Health Economics and Market Access strategy for DePuy Synthes Trauma and Spine business units. In total, Ann has over 20 years of industry experience in healthcare economics, market access, and outcomes research with over 40 conference presentations and publications in peer-reviewed journals. She holds two degrees, a M.S. in Health Economics and Outcomes Research from Thomas Jefferson University and a M.S. in genetics from the University of Wisconsin, Madison.
Disclosure information not submitted.